Your browser doesn't support javascript.
loading
SARS-CoV-2-specific memory B cells can persist in the elderly who have lost detectable neutralizing antibodies.
Jeffery-Smith, Anna; Burton, Alice R; Lens, Sabela; Rees-Spear, Chloe; Davies, Jessica; Patel, Monika; Gopal, Robin; Muir, Luke; Aiano, Felicity; Doores, Katie J; Chow, J Yimmy; Ladhani, Shamez N; Zambon, Maria; McCoy, Laura E; Maini, Mala K.
Afiliação
  • Jeffery-Smith A; Division of Infection and Immunity, Institute of Immunity and Transplantation, University College London (UCL), London, United Kingdom.
  • Burton AR; Virus Reference Department, Public Health England (now called UK Health Security Agency [UKHSA]), London, United Kingdom.
  • Lens S; Blizard Institute, Queen Mary University of London, London, United Kingdom.
  • Rees-Spear C; Division of Infection and Immunity, Institute of Immunity and Transplantation, University College London (UCL), London, United Kingdom.
  • Davies J; Division of Infection and Immunity, Institute of Immunity and Transplantation, University College London (UCL), London, United Kingdom.
  • Patel M; Division of Infection and Immunity, Institute of Immunity and Transplantation, University College London (UCL), London, United Kingdom.
  • Gopal R; Division of Infection and Immunity, Institute of Immunity and Transplantation, University College London (UCL), London, United Kingdom.
  • Muir L; Virus Reference Department, Public Health England (now called UK Health Security Agency [UKHSA]), London, United Kingdom.
  • Aiano F; Virus Reference Department, Public Health England (now called UK Health Security Agency [UKHSA]), London, United Kingdom.
  • Doores KJ; Division of Infection and Immunity, Institute of Immunity and Transplantation, University College London (UCL), London, United Kingdom.
  • Chow JY; Immunisation and Countermeasures Division, Public Health England (now called UKHSA), London, United Kingdom.
  • Ladhani SN; Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, United Kingdom.
  • Zambon M; London Coronavirus Response Cell, Public Health England (now called UKHSA), London, United Kingdom.
  • McCoy LE; Immunisation and Countermeasures Division, Public Health England (now called UKHSA), London, United Kingdom.
  • Maini MK; Virus Reference Department, Public Health England (now called UK Health Security Agency [UKHSA]), London, United Kingdom.
J Clin Invest ; 132(2)2022 01 18.
Article em En | MEDLINE | ID: mdl-34843448
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 4_TD Problema de saúde: 4_pneumonia Assunto principal: Anticorpos Neutralizantes / SARS-CoV-2 / COVID-19 / Células B de Memória / Memória Imunológica / Anticorpos Antivirais Limite: Female / Humans / Male Idioma: En Revista: J Clin Invest Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 4_TD Problema de saúde: 4_pneumonia Assunto principal: Anticorpos Neutralizantes / SARS-CoV-2 / COVID-19 / Células B de Memória / Memória Imunológica / Anticorpos Antivirais Limite: Female / Humans / Male Idioma: En Revista: J Clin Invest Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido